Galmed Pharmaceuticals
GLMD
#10262
Rank
S$4.08 M
Marketcap
$1.81
Share price
1.47%
Change (1 day)
-69.89%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Galmed Pharmaceuticals CIK: 0001595353
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Galmed Pharmaceuticals only files 20-F reports

Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2018

20-F Annual Report 2018

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2017

20-F Annual Report 2017

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2016

20-F Annual Report 2016

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2015

20-F Annual Report 2015

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report 2014

20-F Annual Report 2014

Language: English

View Annual Report (20-F)